Page 53
Notes:
conferenceseries
.com
Volume 7, Issue 4(Suppl)
J Gastrointest Dig Syst, an open access journal
ISSN: 2161-069X
Gastro Congress 2017
September 11-12, 2017
September 11-12, 2017 | Paris, France
12
th
Euro-Global Gastroenterology Conference
Rose hip in treatment of non-alcoholic fatty liver disease (NAFLD)
Hadis Sabour
Tehran University of Medical Sciences, Iran
N
on-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in Iran. The disorder is being recognized
increasingly in the uniformly obese and no obese people. However, the lack of specific reversal agents has made the management
of (NAFLD). Rose hip has been used traditionally to treat a range of conditions including diabetes based on anti-insulin effect of
rosehip.This study on 25 patients illustrates the role of rosehip in improving patient Non-alcoholic fatty liver disease while highlighting
the importance of information and education about the availability and appropriate use of this herb in treatment of fatty liver.
Biography
Hadis Sabour is currently working as Assistant Prof. in Brain and Spinal Injury Research Center (BASIR), Neuroscience Institute, Tehran University of Medical
Sciences (2016 to date). He has worked as Researcher, Diet Consultant, Brain and Spinal Injury Research Center (BASIR), Neuroscience Institute, Tehran
University of Medical Sciences (2006- to 2015) and Researcher, Endocrine and Metabolism Research Center, Tehran University of Medical Sciences (2005-2007).
He has completed his PhD (2011) in Nutritional Sciences from Tehran University of Medical Sciences, Tehran and MD in 2000 from Tabriz University of Medical
Sciences, Tabriz, Iran.
hsabour@sina.tums.ac.irHadis Sabour, J Gastrointest Dig Syst 2017, 7:4(Suppl)
DOI: 10.4172/2161-069X-C1-053